DXR ($DXR) Insider Trading & Smart Money Activity
$DXR has 7 insider trades on file. Insiders filed 7 Form 4 transactions in the last 12 months, none of them open-market purchases or sales.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 0
- Net insider $ (12 mo)
- $0
- Congress trades (12 mo)
- 0
- 13F moves on file
- 0
- Analyst ratings on file
- 0
DXR insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q2 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q3 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 0 / 0 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All DXR insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Insider | Robert MichelChief Financial Officer | Buy (Grant or award) | 12K sh | +1.5% | +5.6% | — | |||||
| Insider | Joy Goudie | Buy (Grant or award) | 2.50K sh | +1.5% | +5.6% | — | |||||
| Insider | Edward Feuer | Buy (Grant or award) | 2.50K sh | +1.5% | +5.6% | Read | |||||
| Insider | Feldschuh Michael RichardChief Executive Officer | Buy (Grant or award) | 30K sh | +1.5% | +5.6% | Read | |||||
| Insider | Feldschuh Jonathan AdamChief Scientific Officer | Buy (Grant or award) | 25K sh | +1.5% | +5.6% | — | |||||
| Insider | Caleb Desrosiers | Buy (Grant or award) | 2.50K sh | +1.5% | +5.6% | — | |||||
| Insider | Henry Cremisi | Buy (Grant or award) | 2.50K sh | +1.5% | +5.6% | — |
1W / 1M / 6M = how DXR moved from the trade or filing date.
Insider trading in DXR: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Robert Michel | Chief Financial Officer | 1 | — | Jun 23, 2026 | |
| Joy Goudie | 1 | — | Jun 23, 2026 | ||
| Edward Feuer | 1 | — | Jun 23, 2026 | ||
| Feldschuh Michael Richard | Chief Executive Officer | 1 | — | Jun 23, 2026 | |
| Feldschuh Jonathan Adam | Chief Scientific Officer | 1 | — | Jun 23, 2026 | |
| Caleb Desrosiers | 1 | — | Jun 23, 2026 | ||
| Henry Cremisi | 1 | — | Jun 23, 2026 |
Frequently asked questions
What is the latest insider trade in DXR?
Robert Michel, Chief Financial Officer filed a buy (grant or award) of 12K sh on Jun 23, 2026.
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.